The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin

NCT06223685 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome
Small Intestinal Bacterial Overgrowth
SIBO

Interventions

DRUG: Rifaximin (Xifaxan) 1200mg/day
DIETARY_SUPPLEMENT: Probiotic
DRUG: XIFAXAN® (Rifaximin) 1600mg/day

Sponsor

Pomeranian Medical University Szczecin